Time Restricted-EAting for Type 2 Diabetes and MEtabolic Health: the TEA TIME Trial
Time Restricted-eating and Metabolic Health in Patients With Type 2 Diabetes
Mount Sinai Hospital, Canada
112 participants
Feb 1, 2026
INTERVENTIONAL
Conditions
Summary
Time-restricted eating - where no food is consumed over a period of time - has been shown to promote weight loss and improve cardio-metabolic function. In individuals with type 2 diabetes, it is also been shown to improve glucose control. The investigators propose a randomized controlled trial to determine whether time-restricted eating is an effective therapeutic strategy that can preserve pancreatic beta-cell function and improve glycemic control early in participants with type 2 diabetes.
Eligibility
Plain Language Summary
Simplified for easier understanding
This is a simplified summary. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
18 hours of fasting and 6 hour window of eating (between 2 to 8 PM) every day for 52 weeks.
standard lifestyle recommendations as per Diabetes Canada guidelines \[where patients are encouraged to maintain regularity in timing and spacing of meals with no specific recommendation regarding hours of fasting\]
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07272460